Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism

J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1708-e1716. doi: 10.1210/clinem/dgaa974.

Abstract

Context: The diagnostic work-up of primary aldosteronism (PA) includes screening and confirmation steps. Case confirmation is time-consuming, expensive, and there is no consensus on tests and thresholds to be used. Diagnostic algorithms to avoid confirmatory testing may be useful for the management of patients with PA.

Objective: Development and validation of diagnostic models to confirm or exclude PA diagnosis in patients with a positive screening test.

Design, patients, and setting: We evaluated 1024 patients who underwent confirmatory testing for PA. The diagnostic models were developed in a training cohort (n = 522), and then tested on an internal validation cohort (n = 174) and on an independent external prospective cohort (n = 328).

Main outcome measure: Different diagnostic models and a 16-point score were developed by machine learning and regression analysis to discriminate patients with a confirmed diagnosis of PA.

Results: Male sex, antihypertensive medication, plasma renin activity, aldosterone, potassium levels, and the presence of organ damage were associated with a confirmed diagnosis of PA. Machine learning-based models displayed an accuracy of 72.9%-83.9%. The Primary Aldosteronism Confirmatory Testing (PACT) score correctly classified 84.1% at training and 83.9% or 81.1% at internal and external validation, respectively. A flow chart employing the PACT score to select patients for confirmatory testing correctly managed all patients and resulted in a 22.8% reduction in the number of confirmatory tests.

Conclusions: The integration of diagnostic modeling algorithms in clinical practice may improve the management of patients with PA by circumventing unnecessary confirmatory testing.

Keywords: aldosterone; confirmatory testing; machine learning; primary aldosteronism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Hyperaldosteronism / diagnosis*
  • Machine Learning
  • Male
  • Mass Screening / methods
  • Middle Aged
  • Sensitivity and Specificity